Finance

Lists
Why is 000590 up 2,55%?
Dive Deeper
000590:SHE
Guhan Pharmaceutical Group Co Ltd
CNÂ¥8,84
+2,55%
(+0,22) 1D
16 Okt., 15:04:51 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000590...
Open
CNÂ¥8,81
High
CNÂ¥9,06
Low
CNÂ¥8,72
Mkt. cap
2,06 mjd
Avg. vol.
2,96 m
Volume
3,98 m
52-wk high
CNÂ¥12,90
52-wk low
CNÂ¥7,47
EPS
-CNÂ¥0,20
Shares outstanding
239,47 m
No. of employees
1 k
Open
CNÂ¥8,81
High
CNÂ¥9,06
Low
CNÂ¥8,72
Mkt. cap
2,06 mjd
Avg. vol.
2,96 m
Volume
3,98 m
52-wk high
CNÂ¥12,90
52-wk low
CNÂ¥7,47
EPS
-CNÂ¥0,20
Shares outstanding
239,47 m
No. of employees
1 k
News stories
From web sources and news partners
About Guhan Pharmaceutical Group Co Ltd
CEO-
Employees1,06 k
Founded1956
Headquarters-
SectorPharmaceutical industry
Websiteguhan.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
82,38 m
112,86 m
71,67 m
62,51 m
Cost of goods sold
41,46 m
68,55 m
40,99 m
35,83 m
Cost of revenue
41,46 m
68,55 m
40,99 m
35,83 m
Research and development expenses
3,37 m
2,25 m
3,63 m
4,23 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,15 m
42,61 m
32,63 m
28,80 m
Operating expense
29,05 m
56,19 m
37,07 m
35,72 m
Total operating expenses
70,52 m
124,74 m
78,06 m
71,55 m
Operating income
11,86 m
-11,89 m
-6,39 m
-9,04 m
Other non operating income
-6,47 m
-6,19 m
-29,18 k
-57,13 k
EBT including unusual items
2,23 m
-36,85 m
-6,68 m
-6,46 m
EBT excluding unusual items
4,83 m
-17,97 m
-6,80 m
-8,63 m
Income tax expense
28,47 k
-1,84 m
128,94 k
1,71 m
Effective tax rate
1,28%
5,00%
-1,93%
-26,54%
Other operating expenses
-988,48 k
4,95 m
810,79 k
2,59 m
Net income
2,35 m
-35,70 m
-6,81 m
-8,16 m
Net profit margin
2,85%
-31,63%
-9,51%
-13,05%
Earnings per share
-
-
-
-
Interest and investment income
193,02 k
844,37 k
109,80 k
899,59 k
Interest expense
-746,66 k
-733,66 k
-491,09 k
-429,27 k
Net interest expenses
-553,63 k
110,71 k
-381,28 k
470,32 k
Depreciation and amortization charges
-
-
-
-
EBITDA
18,35 m
-4,70 m
796,96 k
-1,83 m
Gain or loss from assets sale
3,44 m
-2,42 m
-
-312,94 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme